Beactica AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Beactica AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10875
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Beactica AB (Beactica) is a drug discovery company develops a pipeline of novel and mechanistically defined small molecule therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis and antibody interaction analysis, discovery of non-competitive ligands and allosteric sites among others. It uses SPR-based small molecule drug discovery platform for lead identification and optimization. The company works in strategic collaborations with pharmaceutical companies to develop small molecule therapeutics. Beactica is headquartered in Uppsala, Sweden.

Beactica AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Beactica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Beactica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Beactica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Beactica AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Beactica Raises Funds Through Venture Financing 10
Beactica Raises Funds through Venture Financing 11
Partnerships 12
Beactica Enters into Research Agreement with Uppsala University and SciLifeLab 12
Beactica Enters into Drug Discovery Agreement with Medivir 13
Beactica Expands Drug Discovery Agreement With Boehringer Ingelheim 14
Beactica Enters Into Research Agreement With Janssen Research & Development 15
Licensing Agreements 16
Dong-A ST Enters into Licensing Agreement with Beactica 16
Beactica AB – Key Competitors 17
Beactica AB – Key Employees 18
Beactica AB – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Nov 06, 2017: Beactica Appoints Erik Wallden and Uli Hacksell to its Board of Directors 20
Government and Public Interest 21
Apr 18, 2018: Beactica wins European Horizon 2020 innovation grant for project targeting aggressive brain tumours 21
Nov 22, 2017: Beactica awarded funding to develop new therapeutics against aggressive brain tumours 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Beactica AB, Pharmaceuticals & Healthcare, Key Facts 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Beactica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Beactica AB, Deals By Therapy Area, 2012 to YTD 2018 8
Beactica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Beactica Raises Funds Through Venture Financing 10
Beactica Raises Funds through Venture Financing 11
Beactica Enters into Research Agreement with Uppsala University and SciLifeLab 12
Beactica Enters into Drug Discovery Agreement with Medivir 13
Beactica Expands Drug Discovery Agreement With Boehringer Ingelheim 14
Beactica Enters Into Research Agreement With Janssen Research & Development 15
Dong-A ST Enters into Licensing Agreement with Beactica 16
Beactica AB, Key Competitors 17
Beactica AB, Key Employees 18
Beactica AB, Other Locations 19

List of Figures
Beactica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Beactica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Beactica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Beactica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Beactica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Beactica AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IPCA Laboratories Ltd (IPCALAB):製薬・医療:M&Aディール及び事業提携情報
    Summary IPCA Laboratories Ltd (IPCA) is a pharmaceutical company which manufactures and markets active pharmaceutical ingredients, generics and formulations for various therapeutic areas. The company’s active pharmaceutical ingredients include anti-hypertensive, anti-malarial, diuretic and anthelmin …
  • Valmet Corp (VALMT):企業の財務・戦略的SWOT分析
    Valmet Corp (VALMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Cathay Pacific Airways Limited:企業の戦略・SWOT・財務分析
    Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Xped Ltd (XPE):企業の財務・戦略的SWOT分析
    Xped Ltd (XPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Comtek Advanced Structures Ltd.:企業の戦略・SWOT・財務情報
    Comtek Advanced Structures Ltd. - Strategy, SWOT and Corporate Finance Report Summary Comtek Advanced Structures Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Entasis Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Entasis Therapeutics Inc (Entasis) discovers and develops anti-infective products for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, a potent inhibitor of class A, C, and D beta-lactamases intended to treat serious gram-negative infections, such as Acin …
  • Beth Israel Deaconess Medical Center Inc-医療機器分野:企業M&A・提携分析
    Summary Beth Israel Deaconess Medical Center Inc (BIDMC), a subsidiary of CareGroup Inc is a healthcare center that offers clinical care, biomedical research and education, health and wellness services. The center offers patient and family care services such as admitting, case management, ethics sup …
  • Intra Energy Corporation Ltd (IEC):企業の財務・戦略的SWOT分析
    Intra Energy Corporation Ltd (IEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Oncopeptides AB (ONCO):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncopeptides AB (Oncopeptides) is a clinical development pharmaceutical company that offers development of oncology therapies to treat multiple myeloma. The company’s lead product candidate Ygalo (melflufen) is a peptidase potentiated cytotoxic drug and a potent anti-angiogenetic compound, a …
  • BellBrook Labs LLC-医療機器分野:企業M&A・提携分析
    Summary BellBrook Labs LLC (BellBrook) is a medical device company that develops detection reagents and screening tools. The company’s biochemical assay technology offers UVO microconduit array platform, chemotaxis assay plate, transcreener HTS assays, ADP² assays, AMP² and GMP² assays, GDP assays, …
  • IndigoVision Group plc (IND):企業の財務・戦略的SWOT分析
    Summary IndigoVision Group plc (IndigoVision) is a developer, manufacturer and distributor of end-to-end IP security management systems. The company’s products include management software, cameras and encoders, specialized cameras, body worn video, integration and recorders. Its camera and encoder’s …
  • Pandora Media, Inc.:企業のM&A・事業提携・投資動向
    Pandora Media, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pandora Media, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Colfax Corporation (CFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Colfax Corp (Colfax) is a manufacturing and engineering company. The company supplies a wide range of products, including heavy-duty centrifugal and axial fans, gas compressors, rotary heat exchangers, and centrifugal and positive displacement pumps; and consumable products and equipment for …
  • RPG Cables Limited:企業の戦略・SWOT・財務情報
    RPG Cables Limited - Strategy, SWOT and Corporate Finance Report Summary RPG Cables Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Royal Boskalis Westminster NV:企業のM&A・事業提携・投資動向
    Royal Boskalis Westminster NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal Boskalis Westminster NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Sumitomo Dainippon Pharma Co Ltd (4506):製薬・医療:M&Aディール及び事業提携情報
    Summary Sumitomo Dainippon Pharma Co Ltd (Sumitomo Dainippon), a subsidiary of Sumitomo Chemical Co., Ltd, develops manufacturers, purchases, sells, imports and exports pharmaceutical products. The company focuses on major therapeutic areas which include central nervous system (CNS), cardiovascular, …
  • Tiscali Group:企業の戦略・SWOT・財務分析
    Tiscali Group - Strategy, SWOT and Corporate Finance Report Summary Tiscali Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Power Assets Holdings Limited:企業の戦略・SWOT・財務情報
    Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Redx Pharma Plc (REDX):企業の財務・戦略的SWOT分析
    Summary Redx Pharma Plc (Redx Pharma), formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics. The company’s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza …
  • Mereo Biopharma Group Plc (MPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆